Gemcitabine followed by radiotherapy in treatment of newly diagnosed high-grade gliomas
Journal of Cancer Metastasis and Treatment · 2016
DOI: 10.20517/2394-4722.2016.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Metastasis and Treatment, 2016. Verfasst von Maha El-Naggar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
The Journal of Cancer Metastasis and Treatment is an open access journal focused on cancer metastasis and treatment, including the occurrence, development, progression, metastasis, and treatment of oncologic disease. It covers basic, translational and clinical research related to cancer cell biology, genomics, precision medicine, oncology internal medicine, radiotherapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neurooncology, etc.
Zitieren
APA
El-Naggar, M., Omar, M., Elgeriany, A., Peters, G. J., Mostafa, A., & Shehata, S. (2016). Gemcitabine followed by radiotherapy in treatment of newly diagnosed high-grade gliomas. Journal of Cancer Metastasis and Treatment. https://doi.org/10.20517/2394-4722.2016.15
Vancouver
El-Naggar M, Omar M, Elgeriany A, Peters GJ, Mostafa A, Shehata S. Gemcitabine followed by radiotherapy in treatment of newly diagnosed high-grade gliomas. Journal of Cancer Metastasis and Treatment. 2016. doi:10.20517/2394-4722.2016.15
BibTeX
@article{ElNaggar2016,
author = {El-Naggar, Maha and Omar, Mervat and Elgeriany, Ahmed and Peters, Godefridus J. and Mostafa, Amina and Shehata, Samir},
title = {Gemcitabine followed by radiotherapy in treatment of newly diagnosed high-grade gliomas},
journal = {Journal of Cancer Metastasis and Treatment},
year = {2016},
doi = {10.20517/2394-4722.2016.15}
}
EUVIMED